3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
13
Neoplasms
5
Neoplasm Metastasis
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Neoplasms by Site
2
Liposarcoma
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Breast Diseases
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Recurrent Ovarian High Grade Serous Adenocarcinoma
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Leiomyosarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Hemangiosarcoma
1
HR+/HER2- Breast Cancer
1
Glioma
1
Interventions
pertuzumab
2
Trastuzumab
2
Taxes
2
Paclitaxel
2
High-Energy Shock Waves
2
Docetaxel
2
Biopsy
2
trastuzumab biosimilar HLX02
1
pembrolizumab
1
Watchful Waiting
1
Transcutaneous Electric Nerve Stimulation
1
Standard of Care
1
Specimen Handling
1
Radiation Dose Hypofractionation
1
Practice Guidelines as Topic
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Observation
1
Minoxidil
1
Methods
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Educational Status
1
Early Intervention, Educational
1
Disulfides
1
Carboplatin
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage I Breast Cancer AJCC v8
×
abemaciclib
×
30 days
×
Clear all
No trials found.